Biomarkers in anal cancer: from biological understanding to stratified treatment

被引：46

作者：

Jones, Christopher M. ^{[1
,2
]}

Goh, Vicky ^{[3
,4
]}

Sebag-Montefiore, David ^{[1
,2
]}

Gilbert, Duncan C. ^{[5
]}

机构：

[1] Leeds Teaching Hosp NHS Trust, Leeds Canc Ctr, Leeds LS9 7TF, W Yorkshire, England

[2] Univ Leeds, Leeds Inst Canc & Pathol, Leeds LS9 7TF, W Yorkshire, England

[3] Kings Coll London, Div Imaging Sci & Biomed Engn, London SE1 7EH, England

[4] Guys & St Thomas NHS Fdn Trust, Dept Radiol, London SE1 7EH, England

[5] Royal Sussex Cty Hosp, Sussex Canc Ctr, Eastern Rd, Brighton BN2 5BE, E Sussex, England

来源：

BRITISH JOURNAL OF CANCER | 2017年 / 116卷 / 02期

关键词：

anal cancer; chemoradiotherapy; HPV; squamous cell carcinoma of the anus; human papilloma virus; biomarkers; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; SURVIVAL; MUTATIONS; CHEMORADIOTHERAPY; P16(INK4A); EXPRESSION; REVEALS; HEAD;

D O I：

10.1038/bjc.2016.398

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Squamous cell carcinomas of the anus and anal canal represent a model of a cancer and perhaps the first where level 1 evidence supported primary chemoradiotherapy (CRT) in treating locoregional disease with curative intent. The majority of tumours are associated with infection with oncogenic subtypes of human papilloma virus and this plays a significant role in their sensitivity to treatment. However, not all tumours are cured with CRT and there remain opportunities to improve outcomes in terms of oncological control and also reducing late toxicities. Understanding the biology of ASCC promises to allow a more personalised approach to treatment, with the development and validation of a range of biomarkers and associated techniques that are the focus of this review.

引用

页码：156 / 162

页数：7

共 60 条

[1]

[Anonymous], MUTAT RES

[2]

[Anonymous], EUR C RAD VIENN

[3]

[Anonymous], P INT PAP C LISB

[4]

[Anonymous], EUR C RAD VIENN

[5]

[Anonymous], J CLIN ONCOL S

[6]

[Anonymous], EUR CANC C VIENN

[7] High-sensitivity human papilloma virus genotyping reveals near universal positivity in anal squamous cell carcinoma: Different implications for vaccine prevention and prognosis [J].

Baricevic, Ivona ;

He, Xiaotong ;

Chakrabarty, Bipasha ;

Oliver, Anthony W. ;

Bailey, Charles ;

Summers, Jeff ;

Hampson, Lynne ;

Hampson, Ian ;

Gilbert, Duncan C. ;

Renehan, Andrew G. .

EUROPEAN JOURNAL OF CANCER, 2015, 51 (06) :776-785

[8] Impaired health-related quality of life after chemoradiotherapy for anal cancer: Late effects in a national cohort of 128 survivors [J].

Bentzen, Anne Gry ;

Balteskard, Lise ;

Wanderas, Eva Hoff ;

Frykholm, Gunilla ;

Wilsgaard, Tom ;

Dahl, Olav ;

Guren, Marianne Gronlie .

ACTA ONCOLOGICA, 2013, 52 (04) :736-744

[9] Trends of incidence and survival in squamous-cell carcinoma of the anal canal in France: a population-based study [J].

Bouvier, Anne-Marie ;

Belot, Aurelien ;

Manfredi, Sylvain ;

Jooste, Valerie ;

Uhry, Zoe ;

Faivre, Jean ;

Duport, Nicolas ;

Grabar, Sophie .

EUROPEAN JOURNAL OF CANCER PREVENTION, 2016, 25 (03) :182-187

[10] Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection [J].

Cacheux, Wulfran ;

Rouleau, Etienne ;

Briaux, Adrien ;

Tsantoulis, Petros ;

Mariani, Pascale ;

Richard-Molard, Marion ;

Buecher, Bruno ;

Dangles-Marie, Virginie ;

Richon, Sophie ;

Lazartigues, Julien ;

Jeannot, Emmanuelle ;

Farkhondeh, Fereshteh ;

Sastre-Garau, Xavier ;

de La Rochefordiere, Anne ;

Labib, Alain ;

Falcou, Marie-Christine ;

Stevens, Denise ;

Roth, Arnaud ;

Roman-Roman, Sergio ;

Mitry, Emmanuel ;

Bieche, Ivan ;

Lievre, Astrid .

BRITISH JOURNAL OF CANCER, 2016, 114 (12) :1387-1394

← 1 2 3 4 5 6 →